PetMedix Secures $27M Series B Funding and Joins Forces with Zoetis!

We are thrilled to share some exciting news from PetMedix as we announce a successful funding round that raised an impressive $27,000,000.

This milestone not only reinforces the confidence that investors have in our vision for the future of pet healthcare but also marks a strategic turning point in our journey.

As part of our long-term growth plan, PetMedix will soon be discontinuing our dedicated channel, as we prepare to join forces with Zoetis, a leader in animal health.

The infusion of capital will be instrumental in facilitating a smooth transition and supporting the integration of our services, ensuring that the best in pet medical innovations are seamlessly delivered under the Zoetis banner.

This move aligns with our commitment to continuously enhance and expand the care offered to pets and their families around the world.

By partnering with Zoetis, we are positioning ourselves at the forefront of groundbreaking research and customer-centric solutions that address the evolving needs of the pet healthcare landscape.

The funds will primarily be used to bolster our technological capabilities and enhance service delivery, bringing together the strengths of both organizations to create a unified platform dedicated to better healthcare outcomes.

We invite our loyal community and partners to follow Zoetis channels to stay connected and receive the latest updates on this exciting evolution.

Together, we are confident that this collaboration will drive lasting, positive change in the field of animal health and set the stage for a future rich with innovation and improved care for pets everywhere.